Ó Broin P, Hayde N, Bao Y, Ye B, Calder R B, de Boccardo G, Lubetzky M, Ajaimy M, Pullman J, Colovai A, Akalin E, Golden A
Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.
Division of Pediatric Nephrology, University of Texas Health Science Center, Houston, TX, USA.
Genom Data. 2014 Oct 12;2:357-60. doi: 10.1016/j.gdata.2014.10.005. eCollection 2014 Dec.
Affymetrix Human Gene 1.0-ST arrays were used to assess the gene expression profiles of kidney transplant patients who presented with donor-specific antibodies (DSAs) but showed normal biopsy histopathology and did not develop antibody-mediated rejection (AMR). Biopsy and whole-blood profiles for these DSA-positive, AMR-negative (DSA +/AMR-) patients were compared to both DSA-positive, AMR-positive (DSA +/AMR +) patients as well as DSA-negative (DSA -) controls. While individual gene expression changes across sample groups were relatively subtle, gene-set enrichment analysis using previously identified pathogenesis-based transcripts (PBTs) identified a clear molecular signature involving increased rejection-associated transcripts in AMR - patients. Results from this study have been published in Kidney International (Hayde et al., 2014 [1]) and the associated data have been deposited in the GEO archive and are accessible via the following link: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50084.
采用Affymetrix人类基因1.0-ST芯片评估肾移植患者的基因表达谱,这些患者存在供者特异性抗体(DSA),但活检组织病理学正常且未发生抗体介导的排斥反应(AMR)。将这些DSA阳性、AMR阴性(DSA +/AMR -)患者的活检和全血谱与DSA阳性、AMR阳性(DSA +/AMR +)患者以及DSA阴性(DSA -)对照进行比较。虽然各样本组间的个体基因表达变化相对细微,但使用先前鉴定的基于发病机制的转录本(PBT)进行的基因集富集分析确定了一个明确的分子特征,即AMR -患者中与排斥相关的转录本增加。本研究结果已发表于《国际肾脏杂志》(Hayde等人,2014 [1]),相关数据已存入GEO数据库,可通过以下链接获取:http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50084 。